Professor & Dir Autism Rsch, University of Alberta

Stollery Children's Hospital Foundation Chair in Autism. Renowned for work on Autism Spectrum Disorder (ASD). For 15 years he has co-led a multi-site longitudinal study of high-risk infants to characterize early development of ASD and co-developed the first observational scale to detect signs of ASD in infants which has been adopted internationally. National ASD Project Lead with NeuroDevNet, a Network of Centres of Excellence on neurodevelopmental disabilities; Director, Canadian Autism Research Training Program.

Professor Emeritus, University of Alberta

Kue Young has played a pivotal role in the development of Aboriginal and northern health research in Canada and internationally. He was one of the first researchers in Canada to recognize the emerging diabetes epidemic among First Nations in the early 1980’s. He has contributed substantially to understanding the epidemiology and genetics of diabetes in that population, and its prevention and control. A population health research scientist of the first order, he received the CIHR Senior Investigator award 1998-2008. Dr. Young has authored six books on Aboriginal and circumpolar health, and a ...

Distinguished Research Professor, York University

Renowned applied mathematician Dr. Wu has made foundational contributions to supporting infectious disease public health decision-making strategies based on novel applications of the bifurcation theory, a mathematical theory of long-term epidemiological scenario analyses. Internationally recognized as a powerhouse in dynamical systems and data clustering, his disease modelling research provides critical insights on mechanisms behind complex patterns and is used to accurately forecast disease trends. He is a major contributor to a paradigm shift towards an extensive use of interdisciplinary ...

Ron Worton retired in 2007 from the position of CEO and Scientific Director of the Ottawa Hospital Research Institute, Vice President of Research at the Ottawa Hospital and Professor at the University of Ottawa. He previously served as Geneticist-in-Chief at the Hospital for Sick Children and as the inaugural Scientific Director of the Stem Cell Network. Dr. Worton has served on the boards of many organizations, including the Canadian College of Medical Geneticists, the International Human Genome Organization, Genome Canada, Research Canada (two years as Chair) and the American Society of ...

Professor and Director, Clinical Research Unit, University of Calgary

Dr. Wiebe is an internationally recognized clinical researcher focusing on neurosciences and epilepsy and in evidence based medicine. He specializes in surgical randomized controlled trials, and in patient-centred outcomes. He performed the only randomized trial on brain surgery for epilepsy, which resulted in international treatment guidelines for this condition. Dr. Wiebe has trained numerous clinical researchers, he leads national and international clinical research initiatives, and he plays a major role in establishing educational and clinical care programs in epilepsy around the world.

Faculty of Medicine Distinguished Research Chair, University of Ottawa

Dr. Phil Wells is a Hematologist. He is currently a University of Ottawa Distinguished Research Chair in Translational and AI Research in Venous Thrombosis. He is perhaps best known for pioneering the concept of clinical prediction rules: the "Wells Model for DVT" and the "Wells Model for PE" are taught and used world-wide. He has received over $30 million in peer reviewed research funding and has over 380 publications. His work has been acknowledged through a Canada Research Chair, and several lifetime achievement awards. His current interests are Cancer Associated Thrombosis and AI to ...

Professor, Western University

Charles Weijer is a leading expert on the ethics of randomized controlled trials. Publications on the duty of care in clinical research, the ethical analysis of study benefits and harms, and empowering communities in research have been broadly influential.From 2008 to 2013 Charles co-led a collaboration that produced the first international ethics guidelines for cluster randomized trials. From 2014 to 2018 he collaborated with Dr. Adrian M. Owen on a project exploring the ethics of functional neuroimaging after severe brain injury. Charles’ current work explores ethical issues in pragmatic ...

Professor, University of Toronto

Xiaolin Wei is a Professor and Dalla Lana Chair of Global Health Policy at the Dalla Lana School of Public Health, University of Toronto. Professor Wei is an internationally recognized leader at using implementation science frameworks in health service research, specifically in the control of tuberculosis, diabetes and antimicrobial resistance (AMR). His scholarship has reformed health policies to promote quality and equitable care in COVID-19, tuberculosis, AMR and diabetes at national and global levels. He has served as the Vice President and Secretary General of the International Union ...

Professor Emeritus, Division of General Surgery, University of British Columbia

Lu-Yang Wang holds a Tier 1 Canada Research Chair in Brain Development and Disorders, and is a Senior Scientist at SickKids Research Institute. He is also a Professor in the Department of Physiology at the University of Toronto, where he serves as Associate Chair. He is a distinguished scholar internationally recognized for his paradigm-shifting work on brain plasticity and neurodevelopmental disorders that were published in Nature, Science, Neuron, Science Translational Medicine, and Molecular Psychiatry. He is an exceptional academic leader regularly elected to serve as the chair and/or the ...